Gerhold C, Stonesifer C, Xie D, Norman R
Cureus. 2024; 16(4):e58910.
PMID: 38800207
PMC: 11118888.
DOI: 10.7759/cureus.58910.
Watter H, Milkins R, Chambers C, OBrien B
BMJ Case Rep. 2023; 16(10).
PMID: 37879714
PMC: 10603449.
DOI: 10.1136/bcr-2023-256427.
Glutsch V, Wobser M, Schilling B, Gesierich A, Goebeler M, Kneitz H
Dermatopathology (Basel). 2022; 9(2):148-157.
PMID: 35645230
PMC: 9149841.
DOI: 10.3390/dermatopathology9020019.
Kamata M, Minamisaka T, Imura J, Saitoh K, Shimomura A, Noguchi A
Cureus. 2022; 14(1):e21644.
PMID: 35233321
PMC: 8881242.
DOI: 10.7759/cureus.21644.
Wu Y, Lai Y, Zhang M, Li Z
Diagn Pathol. 2021; 16(1):78.
PMID: 34454530
PMC: 8403415.
DOI: 10.1186/s13000-021-01135-x.
Use of Immunotherapy and Radiation Treatment in the Management of Metastatic Melanoma With Rhabdomyosarcomatous Differentiation.
Gupta A, Wagman R, Kuwadekar A, Scoppetuolo M, Dardik M, Smith F
Adv Radiat Oncol. 2020; 5(1):134-139.
PMID: 32051900
PMC: 7004934.
DOI: 10.1016/j.adro.2019.07.019.
Melanoma with rhabdomyosarcomatous differentiation.
Kuwadekar A, Allard J, Dardik M, Smith F
BMJ Case Rep. 2018; 2018.
PMID: 29880623
PMC: 6011467.
DOI: 10.1136/bcr-2018-224263.
Primary Amelanotic Rhabdoid Melanoma: A Case Report with Review of the Literature.
Kaneko T, Korekawa A, Akasaka E, Rokunohe D, Nakano H, Sawamura D
Case Rep Dermatol. 2015; 7(3):292-7.
PMID: 26594166
PMC: 4650992.
DOI: 10.1159/000441347.
Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.
Bishop J, Thompson L, Cardesa A, Barnes L, Lewis Jr J, Triantafyllou A
Head Neck Pathol. 2015; 9(4):507-18.
PMID: 25757816
PMC: 4651923.
DOI: 10.1007/s12105-015-0624-2.
[Tumors of the scalp: special aspects of selected examples].
Rose C
Hautarzt. 2014; 65(12):1030-6.
PMID: 25315428
DOI: 10.1007/s00105-014-3531-7.
Primary sinonasal mucosal melanoma with aberrant diffuse and strong desmin reactivity: a potential diagnostic pitfall!.
Smith S, Schmitt A, Carrau R, Iwenofu O
Head Neck Pathol. 2014; 9(1):165-71.
PMID: 24974197
PMC: 4382480.
DOI: 10.1007/s12105-014-0553-5.
Primary malignant rhabdoid melanoma.
Chung B, Ahn I, Cho S, Kim H, Kim K, Park C
Ann Dermatol. 2011; 23(Suppl 2):S155-9.
PMID: 22148039
PMC: 3229054.
DOI: 10.5021/ad.2011.23.S2.S155.
Metastatic melanoma with striking adenocarcinomatous differentiation illustrating phenotypic plasticity in melanoma.
Jalas J, Vemula S, Bezrookove V, LeBoit P, Simko J, Bastian B
Am J Surg Pathol. 2011; 35(9):1413-8.
PMID: 21836492
PMC: 3319763.
DOI: 10.1097/PAS.0b013e31822280d8.
A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.
Gattenlohner S, Jorissen H, Huhn M, Vincent A, Beeson D, Tzartos S
J Biomed Biotechnol. 2010; 2010:187621.
PMID: 20204062
PMC: 2829619.
DOI: 10.1155/2010/187621.
